Your browser doesn't support javascript.
loading
A Phase I Dosing Study of Ferumoxytol for MR Lymphography at 3 T in Patients With Prostate Cancer.
Turkbey, Baris; Agarwal, Harsh K; Shih, Joanna; Bernardo, Marcelino; McKinney, Yolanda L; Daar, Dagane; Griffiths, Gary L; Sankineni, Sandeep; Johnson, Linda; Grant, Kinzya B; Weaver, Juanita; Rais-Bahrami, Soroush; Harisinghani, Mukesh; Jacobs, Paula; Dahut, William; Merino, Maria J; Pinto, Peter A; Choyke, Peter L.
Afiliação
  • Turkbey B; 1 Molecular Imaging Program, National Cancer Institute, National Institutes of Health, 10 Center Dr, MSC 1182, Bldg 10, Rm B3B85, Bethesda, MD 20892-1088.
  • Agarwal HK; 1 Molecular Imaging Program, National Cancer Institute, National Institutes of Health, 10 Center Dr, MSC 1182, Bldg 10, Rm B3B85, Bethesda, MD 20892-1088.
  • Shih J; 2 Philips Healthcare Research North America, Briarcliff Manor, NY.
  • Bernardo M; 3 Biometric Research Branch, Division of Cancer Treatment and Diagnosis, NCI, NIH, Bethesda, MD.
  • McKinney YL; 1 Molecular Imaging Program, National Cancer Institute, National Institutes of Health, 10 Center Dr, MSC 1182, Bldg 10, Rm B3B85, Bethesda, MD 20892-1088.
  • Daar D; 1 Molecular Imaging Program, National Cancer Institute, National Institutes of Health, 10 Center Dr, MSC 1182, Bldg 10, Rm B3B85, Bethesda, MD 20892-1088.
  • Griffiths GL; 1 Molecular Imaging Program, National Cancer Institute, National Institutes of Health, 10 Center Dr, MSC 1182, Bldg 10, Rm B3B85, Bethesda, MD 20892-1088.
  • Sankineni S; 4 Clinical Monitoring Research Program, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, MD.
  • Johnson L; 1 Molecular Imaging Program, National Cancer Institute, National Institutes of Health, 10 Center Dr, MSC 1182, Bldg 10, Rm B3B85, Bethesda, MD 20892-1088.
  • Grant KB; 1 Molecular Imaging Program, National Cancer Institute, National Institutes of Health, 10 Center Dr, MSC 1182, Bldg 10, Rm B3B85, Bethesda, MD 20892-1088.
  • Weaver J; 1 Molecular Imaging Program, National Cancer Institute, National Institutes of Health, 10 Center Dr, MSC 1182, Bldg 10, Rm B3B85, Bethesda, MD 20892-1088.
  • Rais-Bahrami S; 1 Molecular Imaging Program, National Cancer Institute, National Institutes of Health, 10 Center Dr, MSC 1182, Bldg 10, Rm B3B85, Bethesda, MD 20892-1088.
  • Harisinghani M; 5 Urologic Oncology Branch, NCI, NIH, Bethesda, MD.
  • Jacobs P; 6 Department of Radiology, Division of Abdominal Imaging and Interventional Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, MA.
  • Dahut W; 7 Cancer Imaging Program, NCI, NIH, Rockville, MD.
  • Merino MJ; 8 Genitourinary Malignancies Branch, NCI, NIH, Bethesda, MD.
  • Pinto PA; 9 Laboratory of Pathology, NCI, NIH, Bethesda, MD.
  • Choyke PL; 5 Urologic Oncology Branch, NCI, NIH, Bethesda, MD.
AJR Am J Roentgenol ; 205(1): 64-9, 2015 Jul.
Article em En | MEDLINE | ID: mdl-26102381
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Imageamento por Ressonância Magnética / Linfografia / Óxido Ferroso-Férrico / Metástase Linfática Tipo de estudo: Observational_studies Limite: Aged / Humans / Male / Middle aged Idioma: En Revista: AJR Am J Roentgenol Ano de publicação: 2015 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Imageamento por Ressonância Magnética / Linfografia / Óxido Ferroso-Férrico / Metástase Linfática Tipo de estudo: Observational_studies Limite: Aged / Humans / Male / Middle aged Idioma: En Revista: AJR Am J Roentgenol Ano de publicação: 2015 Tipo de documento: Article